Brief: Acelrx Announces Rebranding With Name Change To Talphera Inc

Talphera

09/01/2024 14:43

Jan 9 (Reuters) - AcelRx Pharmaceuticals Inc  ACRX.O :
    * ACELRX ANNOUNCES REBRANDING WITH NAME CHANGE TO TALPHERA,
INC.
    * ACELRX PHARMACEUTICALS INC - TALPHERA WILL BEGIN TRADING
ON
NASDAQ UNDER TRADING SYMBOL "TLPH" EFFECTIVE JANUARY 10
    * ACELRX PHARMACEUTICALS - CO'S LEAD NAFAMOSTAT PRODUCT
CANDIDATE,
NIYAD, IS EXPECTED TO HAVE A PREMARKET APPROVAL SUBMISSION TO
FDA IN H2 OF 2024
    * ACELRX PHARMACEUTICALS INC - FIRST PATIENT IS EXPECTED TO
BE
ENROLLED FOR NEPHRO STUDY IN Q1 OF 2024

Source text for Eikon:  ID:nPnb8GWw1a 
Further company coverage:  ACRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))